ATE473219T1 - Cholinerge enhancer mit verbesserter durchgängigkeit durch die blut-hirn-schranke zur behandlung von krankheiten, die mit kognitiven störungen einhergehen - Google Patents
Cholinerge enhancer mit verbesserter durchgängigkeit durch die blut-hirn-schranke zur behandlung von krankheiten, die mit kognitiven störungen einhergehenInfo
- Publication number
- ATE473219T1 ATE473219T1 AT06792225T AT06792225T ATE473219T1 AT E473219 T1 ATE473219 T1 AT E473219T1 AT 06792225 T AT06792225 T AT 06792225T AT 06792225 T AT06792225 T AT 06792225T AT E473219 T1 ATE473219 T1 AT E473219T1
- Authority
- AT
- Austria
- Prior art keywords
- perency
- blood
- treatment
- improved
- brain barrier
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05020721A EP1777222A1 (en) | 2005-09-22 | 2005-09-22 | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
US78024306P | 2006-03-07 | 2006-03-07 | |
PCT/EP2006/009220 WO2007039138A1 (en) | 2005-09-22 | 2006-09-22 | Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE473219T1 true ATE473219T1 (de) | 2010-07-15 |
Family
ID=40506504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT06792225T ATE473219T1 (de) | 2005-09-22 | 2006-09-22 | Cholinerge enhancer mit verbesserter durchgängigkeit durch die blut-hirn-schranke zur behandlung von krankheiten, die mit kognitiven störungen einhergehen |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP2009508903A (ja) |
AT (1) | ATE473219T1 (ja) |
CY (1) | CY1110822T1 (ja) |
DE (1) | DE602006015338D1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3417862B1 (en) * | 2012-07-27 | 2021-05-05 | Neurodyn Life Sciences Inc. | Enhanced brain bioavailability of galantamine by selected formulations and transmucosal administration of lipophilic prodrugs |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3856594D1 (de) * | 1987-05-04 | 2008-11-27 | Bonnie Davis | Mittel zur behandlung der alzheimer-krankheit |
US6323195B1 (en) * | 1993-10-15 | 2001-11-27 | Aventis Pharmaceuticals Inc. | Galanthamine derivatives as acetylcholinesterase inhibitors |
DE50101827D1 (de) * | 2000-03-31 | 2004-05-06 | Sanochemia Pharmazeutika Ag Wi | Neue derivate und analoga von galanthamin |
AT414125B (de) * | 2003-09-29 | 2006-09-15 | Sanochemia Pharmazeutika Ag | Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln |
-
2006
- 2006-09-22 AT AT06792225T patent/ATE473219T1/de active
- 2006-09-22 JP JP2008531615A patent/JP2009508903A/ja active Pending
- 2006-09-22 DE DE602006015338T patent/DE602006015338D1/de active Active
-
2010
- 2010-10-07 CY CY20101100895T patent/CY1110822T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1110822T1 (el) | 2015-06-10 |
DE602006015338D1 (de) | 2010-08-19 |
JP2009508903A (ja) | 2009-03-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE540941T1 (de) | 1-ä2-(2,4-dimethylphenylsulfanyl)phenylüpiperaz n als verbindung mit kombinierter serotoninwiederaufnahme-, 5-ht3- und 5-ht1a- aktivität zur behandlung kognitiver störungen | |
ATE399155T1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
ATE424386T1 (de) | Pyridin-verbindungen für die behandlung von prostaglandin-vermittelten krankheiten | |
ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
ATE519488T1 (de) | Aminopyrazin-analoga zur behandlung von glaukomen und anderen durch rho-kinase verursachten krankheiten | |
ATE429218T1 (de) | Pinolensäure zur behandlung von übergewicht | |
DE602006019838D1 (de) | Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten | |
ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
WO2007038459A3 (en) | Carboxyamine compounds and their use in the treatment of hdac dependent diseases | |
GEP20115172B (en) | Bicyclic cinnamide compound | |
EA201000714A1 (ru) | Соединение альфа-(n-сульфонамидо)ацетамида в качестве ингибитора продуцирования бета амилоидного пептида | |
DE602006017980D1 (de) | 3,4-substituierte pyrrolidin-derivate zur behandlung von hypertonie | |
ATE482709T1 (de) | Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
LTC2805723I2 (lt) | Kladribino režimas, skirtas išsėtinei sklerozei gydyti | |
DE502006008804D1 (de) | Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen | |
ITRM20050179A1 (it) | Composizione impiegabile per il trattamento delle patologie paradontali. | |
MA28493B1 (fr) | Sulfonamides destinés au traitement de troubles neurodégénératifs | |
DE502004010131D1 (de) | Pyridopyrimidinone zur behandlung von krebserkrankungen | |
DE602006003094D1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit | |
ATE424823T1 (de) | 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin- derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
ATE517877T1 (de) | Neue arzneimittel zur behandlung von atemwegserkrankungen | |
ATE504297T1 (de) | Visnadin zur behandlung von kopfhautjucken | |
DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
DE602005015697D1 (de) | Te zur behandlung von alzheimer-krankheit | |
DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1940817 Country of ref document: EP |